# The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma

> **NCT06707025** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hadassah Medical Organization** · enrollment: 50 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06707025
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-10
- **Primary completion:** 2024-11-01
- **Final completion:** 2026-10-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06707025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06707025, "The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06707025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
